J. Pantarotto

发表

Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)

Anurag K. Singh, P. Iyengar, H. Choy, 2016 .

Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial.

S. Senan, B. Slotman, J. R. van Sörnsen de Koste, 2009, International Journal of Radiation Oncology, Biology, Physics.

Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies.

Suresh Senan, S. Senan, A. Vincent, 2008, International journal of radiation oncology, biology, physics.

Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements.

J. Cygler, G. Perry, J. Pantarotto, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)

J. Pantarotto, R. MacRae, R. Pathak, 2019, Clinical and translational radiation oncology.

Regional process redesign of lung cancer care: a learning health system pilot project.

C. Dennie, J. Pantarotto, D. Maziak, 2018, Current oncology.

Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatm

J. Pantarotto, R. MacRae, V. Nair, 2014, International journal of radiation oncology, biology, physics.

Adrenal oligometastasis cured with stereotactic ablative radiotherapy

J. Pantarotto, S. Malone, J. Malone, 2020, Radiology case reports.

A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases

G. Pond, B. Fisher, B. Yaremko, 2019, Cureus.

Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

T. Kim, K. Goodman, L. Dawson, 2014, Practical radiation oncology.

Inferring Positions of Tumor and Nodes in Stage III Lung Cancer from Multiple Anatomical Surrogates Using 4D CT

T. McAvoy, W. D'Souza, S. Senan, 2010 .

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)

Ashutosh Kumar Singh, P. Iyengar, H. Choy, 2016 .

Radical Treatment of Stage II Non–small‐cell Lung Cancer With Nonsurgical Approaches: A Multi‐institution Report of Outcomes

J. Pantarotto, N. Leighl, P. Wheatley‐Price, 2018, Clinical lung cancer.

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer

J. Pantarotto, R. MacRae, G. Cook, 2017, Clinical and translational radiation oncology.

Lung cancer diagnosis transformation: Aligning the people, processes, and technology sides of the learning system.

C. Dennie, J. Pantarotto, D. Maziak, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

A. Bezjak, J. V. van Meerbeeck, C. Faivre-Finn, 2017, The Lancet. Oncology.

Clinical Specialist Radiation Therapist in Palliative Radiation Therapy: Report of an Orientation, Training, and Support Program.

M. Gaudet, J. Pantarotto, K. Dennis, 2019, Journal of medical imaging and radiation sciences.

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1–3 metastases

G. Pond, B. Fisher, L. Stitt, 2016, Journal of Neuro-Oncology.

Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers

J. Pantarotto, S. Gilbert, A. Bang, 2019, Clinical and translational radiation oncology.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Anurag K. Singh, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC

Anurag K. Singh, P. Iyengar, H. Choy, 2016 .

CyberKnife for inoperable renal tumors: Canadian pioneering experience.

I. Cagiannos, R. Breau, J. Pantarotto, 2013, The Canadian journal of urology.

CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).

A. Bezjak, C. Faivre-Finn, P. Lorigan, 2016 .

Identifying barriers to accrual in radiation oncology randomized trials.

S. Senan, A. Louie, D. Palma, 2017, Current oncology.

Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.

J. Pantarotto, N. Leighl, P. Wheatley‐Price, 2016, Lung cancer.

The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.

A. Bezjak, L. Dawson, T. Purdie, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prognostic factors in the radical nonsurgical treatment of stage IIIB non-small-cell lung cancer.

J. Pantarotto, E. Sabri, P. Wheatley‐Price, 2014, Clinical lung cancer.

Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

L. Eapen, S. Dahrouge, J. Pantarotto, 2007, BJU international.

Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy.

R. Thornhill, C. Dennie, J. Pantarotto, 2017, Quantitative imaging in medicine and surgery.

Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature

J. Pantarotto, K. Dennis, R. Kamel, 2023, Cancers.

Pan-Canadian Consensus Recommendations for Proton Beam Therapy Access in Canada.

J. Greenland, S. Tyldesley, B. McCurdy, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer Clinic Redesign: Opportunities for Resource Optimization

J. Pantarotto, D. Stewart, M. Reaume, 2022, Current oncology.

Impact of patient selection, disease progression, and adverse events on esophageal cancer outcomes after trimodality therapy.

A. Seely, J. Pantarotto, D. Jonker, 2012, The Annals of thoracic surgery.

Feasibility, Detectability, and Experience With Platinum Seed Internal Fiducial Markers for CT-MRI Fusion and Real-time Tumor Tracking During Stereotactic Ablative Radiation Therapy

J. Pantarotto, E. Vandervoort, L. Avruch, 2012 .

Inferring positions of tumor and nodes in Stage III lung cancer from multiple anatomical surrogates using four-dimensional computed tomography.

Suresh Senan, Warren D D'Souza, Thomas J McAvoy, 2010, International journal of radiation oncology, biology, physics.

Time to Diagnosis and Treatment with Palliative Radiotherapy among Inuit Patients with Cancer from the Arctic Territory of Nunavut, Canada.

B. Slotman, M. Gaudet, J. Pantarotto, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.

J. Pantarotto, V. Nair, 2014, World journal of radiology.

Implementing a one-day testing model improves timeliness of workup for patients with lung cancer.

J. Pantarotto, D. Maziak, M. Fung-Kee-Fung, 2019, Current oncology.

Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy

A. Bezjak, A. Hope, J. Pantarotto, 2020, Thoracic cancer.